
    
      This is a non-interventional, descriptive, national, multi-site, longitudinal and prospective
      observational study with adults patients who are suffering from cancer or malignant blood
      disease and whose chemotherapy treatment has induced symptomatic anemia and being treated
      with biosimilar of epoetin to correct haemoglobin levels.
    
  